MedPath

陕西恒诚制药有限公司

Ownership
-
Established
2014-04-28
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

23

NMPA:23

Drug Approvals

Amoxicillin and Clavulanate Potassium Dispersible Tablets

Product Name
盛西凯
Approval Number
国药准字H20030470
Approval Date
Aug 29, 2022
NMPA

Aceclofenac

Product Name
醋氯芬酸
Approval Number
国药准字H20030215
Approval Date
Feb 10, 2022
NMPA

Dioscornin

Product Name
穿龙薯蓣皂苷
Approval Number
国药准字Z61023752
Approval Date
Oct 11, 2021
NMPA

芙蓉抗流感片

Approval Number
国药准字Z20063530
Approval Date
Jul 13, 2020
NMPA

珍菊降压片

Approval Number
国药准字Z20013211
Approval Date
Jul 13, 2020
NMPA

四季三黄软胶囊

Approval Number
国药准字Z20010108
Approval Date
Jul 13, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H20059701
Approval Date
Jun 5, 2020
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H20059705
Approval Date
Jun 5, 2020
NMPA

Cefadroxil Dispersible Tablets

Product Name
赛复喜
Approval Number
国药准字H20000109
Approval Date
Jun 5, 2020
NMPA

Inosine Tablets

Product Name
肌苷片
Approval Number
国药准字H20059698
Approval Date
Jun 5, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.